10.3410/f.1119928.576041 27 KnopikV
6 NETs-targeted therapy: possibilities and limitations Current clinical treatments for ECMO-related acute organ injury, primarily focus on symptomatic support, as well as anti-inflammatory and anticoagulants
It upregulates the expression of genes involved in lipid and glucose metabolism while increasing mitochondrial density in skeletal muscle
compared to WT controls
Thanks ALL INGREDIENTS All Ingredients Aqua/Water/Eau, Glycerin, Sodium Laureth Sulfate, Cocamidopropyl Betaine, PEG-120 Methyl Glucose Dioleate, PEG-40 Hydrogenated Castor Oil, PEG-7 Glyceryl Cocoate, Polysorbate 20, Alcohol Denat., Sodium Chloride, Phenoxyethanol, Panthenol, Melaleuca Alternifolia Leaf Oil/Melaleuca Alternifolia (Tea Tree) Leaf Oil, Sodium Benzoate, Calophyllum Inophyllum Seed Oil, Citric Acid, Allantoin, Menthol, Butyl Methoxydibenzoylmethane, Limonene, Sodium Hydroxide, Leptospermum Petersonii Oil, Tocopherol, CI 19140/Yellow 5, Caramel, CI 42090/Blue 1
60 min (red arrow)